Compagnie Lombard Odier SCmA’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $249K | Hold |
|
|||||
|
2025
Q2 | $190K | Hold |
|
|||||
|
2025
Q1 | $241K | Hold |
|
|||||
|
2024
Q4 | $351K | Hold |
|
|||||
|
2024
Q3 | $317K | Hold |
|
|||||
|
2024
Q2 | $422K | Buy |
|
|||||
|
2024
Q1 | $235K | Hold |
|
|||||
|
2023
Q4 | $239K | Hold |
|
|||||
|
2023
Q3 | $152K | Hold |
|
|||||
|
2023
Q2 | $364K | Hold |
|
|||||
|
2023
Q1 | $264K | Sell |
|
|||||
|
2022
Q4 | $233K | Hold |
|
|||||
|
2022
Q3 | $307K | Sell |
|
|||||
|
2022
Q2 | $407K | Hold |
|
|||||
|
2022
Q1 | $457K | Hold |
|
|||||
|
2021
Q4 | $426K | Hold |
|
|||||
|
2021
Q3 | $297K | Hold |
|
|||||
|
2021
Q2 | $569K | Sell |
|
|||||
|
2021
Q1 | $16.6M | Buy |
|
|||||
|
2020
Q4 | $172K | Buy |
|